Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.

The First Affiliated Hospital of Zhengzhou University

6 clinical trials · 6 recruiting · OTHER

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

Trials by The First Affiliated Hospital of Zhengzhou University

RECRUITINGNCT07169656

Observation Study on Reducing the Risk of Liver Cancer Associated With Hepatitis B (Zhiyuan) Project.

This study is a multicenter, prospective, observational real-world study designed to investigate and analyze the current treatment patterns of chronic hepatitis B (CHB) across 200...

Sponsor: The First Affiliated Hospital of Zhengzhou UniversityEnrolling: 1500020 locations
Chronic Hepatitis b
RECRUITINGPhase 2NCT07294664

PD1/TGFβ In Combination With EZH2 And Chemotherapy For First - Line Treatment Of Gastric Cancer

Immunotherapy combined with chemotherapy has become the standard first-line treatment regimen for gastric cancer. However, a subset of patients still fail to benefit or derive...

Sponsor: The First Affiliated Hospital of Zhengzhou UniversityEnrolling: 361 location
Advanced Gastric CancerSHR1701
RECRUITINGPhase 2NCT06718205

Nimotuzumab Combined With Sintilimab and Chemotherapy for Advanced Esophageal Squamous Cell Carcinoma

This study is a prospective, single-arm, multicenter study. The patients were given chemotherapy with nimotuzumab and sindilimab. To analyze the efficacy and safety of nimotuzumab...

Sponsor: The First Affiliated Hospital of Zhengzhou UniversityEnrolling: 1121 location
Esophageal Cancer
RECRUITINGPhase 2NCT05182944

A Study of Perioperative Camrelizumab Combined With Chemotherapy in Patients With Resectable ESCC

The purpose of this study is to observe and evaluate the efficacy and safety of camrelizumab combined with albumin paclitaxel and cisplatin as perioperative treatment of advanced...

Sponsor: The First Affiliated Hospital of Zhengzhou UniversityEnrolling: 1301 location
Esophageal Cancer
RECRUITINGPhase 2NCT07016724

Neoadjuvant Radiochemotherapy Combined With Cadonilizumab for Local Advanced Esophageal Squamous Cell Cancer

Esophageal squamous cell cancer (ESCC) has a high incidence in China. Although the fast development of immune check point inhibitors (ICIs), the rate of pCR is limited with the...

Sponsor: The First Affiliated Hospital of Zhengzhou UniversityEnrolling: 2081 location
Esophageal Squamous Cell Carcinoma
RECRUITINGNCT07463664

Clinical Outcomes of Drug-Coated Balloons in the Treatment of Patients With Coronary De Novo Chronic Total Occlusion...

The aim of this study is to evaluate the long-term efficacy and safety of drug-coated balloon (DCB) strategies, including DCB alone or hybrid strategies of DCB and drug-eluting...

Sponsor: The First Affiliated Hospital of Zhengzhou UniversityEnrolling: 20018 locations
Chronic Total Occlusions of Coronary ArteriesChronic Total Occlusion (CTO)Coronary Artery Disease (CAD)